Zhao Wang

95, Yong An Road
Xicheng, 100050, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 202 publications

All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia.

All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia.

Journal: NEJM evidence
Published: July 28, 2026

Hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis diagnosed by bone marrow smear microscopy and metagenomic next-generation sequencing: A case report and review of literature.

Hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis diagnosed by bone marrow smear microscopy and metagenomic next-generation sequencing: A case report and review of literature.

Journal: Diagnostic microbiology and infectious disease
Published: April 09, 2026

Golidocitinib as salvage therapy before allogeneic hematopoietic stem cell transplantation in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Golidocitinib as salvage therapy before allogeneic hematopoietic stem cell transplantation in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Journal: Haematologica
Published: March 31, 2026

Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial.

Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial.

Journal: Nature communications
Published: October 15, 2025

Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies.

Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies.

Journal: Frontiers in immunology
Published: September 30, 2025

Phase 1 study of zanubrutinib plus lenalidomide for patients with relapsed/refractory diffuse large B-cell lymphoma.

Phase 1 study of zanubrutinib plus lenalidomide for patients with relapsed/refractory diffuse large B-cell lymphoma.

Journal: Blood advances
Published: September 18, 2025

Intrinsic capacity across the adult lifespan in China: baseline analysis from the nationwide longitudinal PENG ZU cohort.

Intrinsic capacity across the adult lifespan in China: baseline analysis from the nationwide longitudinal PENG ZU cohort.

Journal: GeroScience
Published: September 04, 2025

Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia.

Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia.

Journal: Journal of hematology & oncology
Published: September 02, 2025

Hemophagocytic lymphohistiocytosis poses a substantial socio-economic burden in China.

Hemophagocytic lymphohistiocytosis poses a substantial socio-economic burden in China.

Journal: Chinese medical journal
Published: August 21, 2025

The effectiveness of etoposide-containing chemotherapy regimens in the initial treatment of Hemophagocytic Syndrome in pregnancy.

The effectiveness of etoposide-containing chemotherapy regimens in the initial treatment of Hemophagocytic Syndrome in pregnancy.

Journal: Hematology (Amsterdam, Netherlands)
Published: August 06, 2025

Splenectomy does not improve survival in chronic active Epstein-Barr virus disease patients.

Splenectomy does not improve survival in chronic active Epstein-Barr virus disease patients.

Journal: Annals of hematology
Published: July 28, 2025

Monocyte/macrophages may exert prominent roles in macrophage activation syndrome.

Monocyte/macrophages may exert prominent roles in macrophage activation syndrome.

Journal: Annals of hematology
Published: May 14, 2025
Showing 1-12 of 202

Last Updated: 09/26/2026